Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Decidual Stromal Cells vs Best Available Treatment in Steroid-resistant Severe Acute GvHD
NCT05132166Phase 2Active, not recruiting
- Sponsor
- University Health Network
- Start
- Dec 2021
- Primary completion
- Apr 2026
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of decidua stroma cells in graft-versus-host disease (GVHD), sponsored by University Health Network. Started Dec 2021; status: active, not recruiting.
02
Drugs
decidua stroma cells
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NCT05132166.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05132166.